Chief Quality Officer
Scott Texley is the Lead Quality Executive for all of Xenter’s business units. His career spans over 30 years of diverse global experience within the medical/healthcare industry. During his extensive professional career, he has held various executive leadership and transformational management positions within Quality, Regulatory Compliance, Enterprise/Portfolio/Program Management and Marketing. His Medical Device experience spans a diverse set of global markets and therapies including Cardiovascular, Peripheral Interventions, Structural Heart, Neurovascular, Heart Failure, Cardiac Rhythm Management and Electrophysiology. Prior to Xenter, Mr. Texley has held Senior Vice President/Vice President/Leadership positions at Abbott Laboratories, St. Jude Medical (now Abbott), Boston Scientific Corporation and Scimed Life Systems, Inc. (now Boston Scientific).
Mr. Texley has extensive experience in formulating strategic organizational, operational and quality planning – as well as establishing world-class portfolio management systems to effectively drive product development from concept through commercialization. He also has significant experience in M&A activities – leading or assisting in the integration of Quality and Product Development systems/technologies for small, medium and large-cap medical organizations. His specific Medical Device Quality/Regulatory Compliance experience encompasses Device Class I – III, Diagnostic & Therapeutic product classifications, IDE, PMA, 510(k), HDE, Combination Products, CE-Marking within MDD 93/42/EEC, ISO 9001/ISO 13485 QMS, Certification Audits, as well as extensive global regulatory agency interactions.
Mr. Texley holds a Bachelor’s Degree in Industrial Technology/Quality Technology from the University of Wisconsin – Stout, an MBA in Leadership from the University of St. Thomas – Minnesota, and has completed numerous Executive Leadership Programs and Industry Certifications.